Murine Hayfever (Sodium Cromoglicate)

Sodium cromoglicate binds to mast cells in the conjunctiva and prevents calcium‑dependent degranulation. This blocks the release of histamine, leukotrienes and other inflammatory mediators, thereby reducing the allergic cascade that causes ocular irritation and inflammation.

The dosage regimen for Murine Hayfever is determined by the prescribing clinician based on the severity of symptoms, patient age and response to therapy. The prescriber will specify the number of drops and frequency appropriate for each individual.

Safety data for sodium cromoglicate in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Murine Hayfever (sodium cromoglicate) is a mast‑cell stabiliser, whereas many alternatives are antihistamine eye drops that block histamine receptors. Mast‑cell stabilisers act upstream to prevent mediator release, offering a complementary or alternative approach for patients who need longer‑term control or who experience side‑effects from antihistamines.

Murine Hayfever should be stored at room temperature, away from direct sunlight and moisture. Keep the product in its original packaging until use, and avoid exposing it to extreme temperatures that could affect its stability.

The product is applied as eye drops. The patient tilts the head back, pulls down the lower eyelid to form a pocket, and instills the prescribed number of drops into the conjunctival sac. The eye should be gently closed for a few seconds to allow distribution.

Serious adverse events, although rare, include severe eye inflammation, keratitis, sudden vision loss and anaphylactic reactions. Patients should seek immediate medical attention if they experience intense pain, rapid vision changes, swelling or signs of a systemic allergic response.

Individuals with a known hypersensitivity to sodium cromoglicate or any excipients in the formulation should avoid the product. It is also contraindicated in eyes with active infection, severe ocular trauma or uncontrolled glaucoma without prior medical advice.